Works by Masuda, Norikazu

Results: 188

Clinical significance of the expression of autophagy-associated marker, beclin 1, in breast cancer patients who received neoadjuvant endocrine therapy.

Published in:

2016

By:

Takayuki Ueno;
Shigehira Saji;
Masahiro Sugimoto;
Norikazu Masuda;
Katsumasa Kuroi;
Nobuaki Sato;
Hiroyuki Takei;
Yutaka Yamamoto;
Shinji Ohno;
Hiroko Yamashita;
Kazufumi Hisamatsu;
Kenjiro Aogi;
Hiroji Iwata;
Shigeru Imoto;
Hironobu Sasano;
Masakazu Toi;
Ueno, Takayuki;
Saji, Shigehira;
Sugimoto, Masahiro;
Masuda, Norikazu

Publication type:

journal article

Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 911, doi. 10.1007/s00280-010-1371-4

By:

Masuda, Hiroko;
Masuda, Norikazu;
Kodama, Yoshinori;
Ogawa, Masami;
Karita, Michiko;
Yamamura, Jun;
Tsukuda, Kazunori;
Doihara, Hiroyoshi;
Miyoshi, Shinichiro;
Mano, Masayuki;
Nakamori, Shoji;
Tsujinaka, Toshimasa

Publication type:

Article

Phase I study of combination therapy with weekly paclitaxel and cyclophosphamide for advanced or recurrent breast cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 1, p. 89, doi. 10.1007/s00280-009-1137-z

By:

Masuda, Norikazu;
Nakayama, Takahiro;
Yamamura, Jun;
Kamigaki, Shunji;
Taguchi, Tetsuya;
Hatta, Mai;
Sakamoto, Junichi

Publication type:

Article

Phase II study of capecitabine and trastuzumab combination chemotherapy in patients with HER2 overexpressing metastatic breast cancers resistant to both anthracyclines and taxanes.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 361, doi. 10.1007/s00280-008-0882-8

By:

Ishida, Takanori;
Kiba, Takayoshi;
Takeda, Motohiro;
Matsuyama, Kotone;
Teramukai, Satoshi;
Ishiwata, Ryota;
Masuda, Norikazu;
Takatsuka, Yuichi;
Noguchi, Shinzaburo;
Ishioka, Chikashi;
Fukushima, Masanori;
Ohuchi, Noriaki

Publication type:

Article

Capecitabine and paclitaxel combination chemotherapy for inoperable or recurrent breast cancer: a phase I dose-finding study by the Kinki Breast Cancer Study Group.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 6, p. 989, doi. 10.1007/s00280-007-0555-z

By:

Masuda, Norikazu;
Taguchi, Tetsuya;
Nakayama, Takahiro;
Shiba, Eiichi;
Watatani, Masahiro;
Kurebayashi, Junichi;
Takatsuka, Yuichi;
Sakamoto, Junichi;
Noguchi, Shinzaburo

Publication type:

Article

Phase II Trial in Japan of Sequential Administration of Weekly Paclitaxel Followed by FEC as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer [KBCSG0206 Trial: Kinki Breast Cancer Study Group (KBCSG)].

Published in:

Oncology, 2010, v. 78, n. 5/6, p. 302, doi. 10.1159/000318169

By:

Taguchi, Tetsuya;
Masuda, Norikazu;
Nakayama, Takahiro;
Motomura, Kazuyoshi;
Tsukamoto, Fumine;
Shimazu, Kenzo;
Nomura, Takashi;
Morimoto, Takashi;
Yamamoto, Hiroshi;
Wakita, Kazuyuki;
Nakano, Yoshiaki;
Yoneda, Kohri;
Inaji, Hideo;
Takatsuka, Yuichi;
Noguchi, Shinzaburo

Publication type:

Article

Analysis of chemical modification of RNA from formalin-fixed samples and optimization of molecular biology applications for such samples.

Published in:

Nucleic Acids Research, 1999, v. 27, n. 22, p. 4436, doi. 10.1093/nar/27.22.4436

By:

Masuda, Norikazu;
Ohnishi, Tadashi;
Kawamoto, Shoko;
Monden, Morito;
Okubo, Kousaku

Publication type:

Article

Retrospective study on the effectiveness of medroxyprogesterone acetate in the treatment of ER-positive/HER2-negative post-menopausal advanced breast cancer: an additional analysis of the JBCRG-C06 Safari study.

Published in:

Japanese Journal of Clinical Oncology, 2023, v. 53, n. 3, p. 203, doi. 10.1093/jjco/hyac184

By:

Kawaguchi, Hidetoshi;
Yamamoto, Yutaka;
Saji, Shigehira;
Masuda, Norikazu;
Nakayama, Takahiro;
Aogi, Kenjiro;
Anan, Keisei;
Ohtani, Shoichiro;
Sato, Nobuaki;
Takano, Toshimi;
Tokunaga, Eriko;
Nakamura, Seigo;
Hasegawa, Yoshie;
Hattori, Masaya;
Fujisawa, Tomomi;
Morita, Satoshi;
Yamaguchi, Miki;
Yamashita, Toshinari;
Yotsumoto, Daisuke;
Toi, Masakazu

Publication type:

Article

Efficacy and exploratory biomarker analysis of entinostat plus exemestane in advanced or recurrent breast cancer: phase II randomized controlled trial.

Published in:

Japanese Journal of Clinical Oncology, 2023, v. 53, n. 1, p. 4, doi. 10.1093/jjco/hyac166

By:

Iwata, Hiroji;
Nakamura, Rikiya;
Masuda, Norikazu;
Yamashita, Toshinari;
Yamamoto, Yutaka;
Kobayashi, Kokoro;
Tsurutani, Junji;
Iwasa, Tsutomu;
Yonemori, Kan;
Tamura, Kenji;
Aruga, Tomoyuki;
Tokunaga, Eriko;
Kaneko, Koji;
Lee, Min-Jung;
Yuno, Akira;
Kawabata, Azusa;
Seike, Toshihiro;
Kaneda, Ayumi;
Nishimura, Yozo;
Trepel, Jane B

Publication type:

Article

Subgroup analysis of Japanese patients in a phase III randomized, controlled study of neoadjuvant atezolizumab or placebo, combined with nab-paclitaxel and anthracycline-based chemotherapy in early triple-negative breast cancer (IMpassion031).

Published in:

Japanese Journal of Clinical Oncology, 2022, v. 52, n. 10, p. 1124, doi. 10.1093/jjco/hyac098

By:

Saji, Shigehira;
Ohsumi, Shozo;
Ito, Mitsuya;
Hayashi, Naoki;
Kobayashi, Kokoro;
Masuda, Norikazu;
Niikura, Naoki;
Yamashita, Toshinari;
Kiyama, Keiichiro;
Hasegawa, Ayumi;
Nakagawa, Shizuka;
Hattori, Masaya

Publication type:

Article

Factors associated with overall survival after recurrence in patients with ER-positive/HER2-negative postmenopausal breast cancer: an ad hoc analysis of the JBCRG-C06 Safari study.

Published in:

Japanese Journal of Clinical Oncology, 2022, v. 52, n. 6, p. 545, doi. 10.1093/jjco/hyac022

By:

Kawaguchi, Hidetoshi;
Yamamoto, Yutaka;
Saji, Shigehira;
Masuda, Norikazu;
Nakayama, Takahiro;
Aogi, Kenjiro;
Anan, Keisei;
Ito, Yoshinori;
Ohtani, Shoichiro;
Sato, Nobuaki;
Takano, Toshimi;
Tokunaga, Eriko;
Nakamura, Seigo;
Hasegawa, Yoshie;
Hattori, Masaya;
Fujisawa, Tomomi;
Morita, Satoshi;
Yamaguchi, Miki;
Yamashita, Hiroko;
Yamashita, Toshinari

Publication type:

Article

Multicenter study of primary systemic therapy with docetaxel, cyclophosphamide and trastuzumab for HER2-positive operable breast cancer: the JBCRG-10 study.

Published in:

Japanese Journal of Clinical Oncology, 2020, v. 50, n. 1, p. 3, doi. 10.1093/jjco/hyz119

By:

Ueno, Takayuki;
Masuda, Norikazu;
Sato, Nobuaki;
Ohtani, Shoichiro;
Yamamura, Jun;
Matsunami, Nobuki;
Kashiwaba, Masahiro;
Takano, Toshimi;
Takahashi, Masato;
Kaneko, Koji;
Ohno, Shinji;
Morita, Satoshi;
Toi, Masakazu

Publication type:

Article

First-line bevacizumab plus paclitaxel in Japanese patients with HER2-negative metastatic breast cancer: subgroup results from the randomized Phase III MERiDiAN trial.

Published in:

Japanese Journal of Clinical Oncology, 2017, v. 47, n. 5, p. 385, doi. 10.1093/jjco/hyx001

By:

Norikazu Masuda;
Masato Takahashi;
Kazuhiko Nakagami;
Yasuhiro Okumura;
Takahiro Nakayama;
Nobuaki Sato;
Kazumitsu Kanatani;
Kosei Tajima;
Masahiro Kashiwaba

Publication type:

Article

Safety and pharmacokinetics of ramucirumab in combination with docetaxel in Japanese patients with locally advanced or metastatic breast cancer: a Phase Ib study.

Published in:

Japanese Journal of Clinical Oncology, 2016, v. 46, n. 12, p. 1088, doi. 10.1093/jjco/hyw127

By:

Norikazu Masuda;
Hiroji Iwata;
Kenjiro Aogi;
Yihuan Xu;
Ayman Ibrahim;
Ling Gao;
Rita Dalal;
Reigetsu Yoshikawa;
Yasutsuna Sasaki

Publication type:

Article

A multicenter Phase II study evaluating the efficacy, safety and pharmacokinetics of trastuzumab emtansine in Japanese patients with heavily pretreated HER2-positive locally recurrent or metastatic breast cancer.

Published in:

Japanese Journal of Clinical Oncology, 2016, v. 46, n. 5, p. 407, doi. 10.1093/jjco/hyw013

By:

Masahiro Kashiwaba;
Yoshinori Ito;
Shintaro Takao;
Hiroyoshi Doihara;
Yoshiaki Rai;
Kazumitsu Kanatani;
Shigemitsu Takashima;
Norikazu Masuda

Publication type:

Article

Intensive vs. Standard Post-Operative Surveillance in High-Risk Breast Cancer Patients (INSPIRE): Japan Clinical Oncology Group Study JCOG1204.

Published in:

Japanese Journal of Clinical Oncology, 2015, v. 45, n. 10, p. 983, doi. 10.1093/jjco/hyv110

By:

Takashi Hojo;
Norikazu Masuda;
Tomonori Mizutani;
Taro Shibata;
Takayuki Kinoshita;
Kenji Tamura;
Fumikata Hara;
Tomomi Fujisawa;
Kenichi Inoue;
Shigehira Saji;
Kenichi Nakamura;
Haruhiko Fukuda;
Hiroji Iwata

Publication type:

Article

Observational Study of Axilla Treatment for Breast Cancer Patients with 1–3 Positive Micrometastases or Macrometastases in Sentinel Lymph Nodes.

Published in:

Japanese Journal of Clinical Oncology, 2014, v. 44, n. 9, p. 876

By:

Oba, Mari S.;
Imoto, Shigeru;
Toh, Uhi;
Wada, Noriaki;
Kawada, Masaya;
Kitada, Masahiro;
Masuda, Norikazu;
Taguchi, Tetsuya;
Minami, Shigeki;
Jinno, Hiromitsu;
Sakamoto, Junichi;
Morita, Satoshi

Publication type:

Article

The Efficacy and Safety of FSK0808, Filgrastim Biosimilar: A Multicenter, Non-randomized Study in Japanese Patients with Breast Cancer.

Published in:

Japanese Journal of Clinical Oncology, 2013, v. 43, n. 9, p. 865, doi. 10.1093/jjco/hyt091

By:

Sagara, Yoshiaki;
Sato, Kazuhiko;
Fukuma, Eisuke;
Higaki, Kenji;
Mizutani, Mitsuhiro;
Osaki, Akihiko;
Takano, Toshimi;
Tokuda, Yutaka;
Ohno, Shinji;
Masuda, Norikazu;
Suzuki, Masato;
Saeki, Toshiaki

Publication type:

Article

A Randomized Controlled Trial Comparing Primary Tumour Resection Plus Systemic Therapy With Systemic Therapy Alone in Metastatic Breast Cancer (PRIM-BC): Japan Clinical Oncology Group Study JCOG1017.

Published in:

Japanese Journal of Clinical Oncology, 2012, v. 42, n. 10, p. 970, doi. 10.1093/jjco/hys120

By:

Shien, Tadahiko;
Nakamura, Kenichi;
Shibata, Taro;
Kinoshita, Takayuki;
Aogi, Kenjiro;
Fujisawa, Tomomi;
Masuda, Norikazu;
Inoue, Kenichi;
Fukuda, Haruhiko;
Iwata, Hiroji

Publication type:

Article

Docetaxel Followed by Fluorouracil/Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy for Patients with Primary Breast Cancer.

Published in:

Japanese Journal of Clinical Oncology, 2011, v. 41, n. 7, p. 867, doi. 10.1093/jjco/hyr081

By:

Iwata, Hiroji;
Sato, Nobuaki;
Masuda, Norikazu;
Nakamura, Seigo;
Yamamoto, Naohito;
Kuroi, Katsumasa;
Kurosumi, Masafumi;
Tsuda, Hitoshi;
Akiyama, Futoshi;
Ohashi, Yasuo;
Toi, Masakazu

Publication type:

Article

Randomized Study of Taxane Versus TS-1 in Women with Metastatic or Recurrent Breast Cancer (SELECT BC).

Published in:

Japanese Journal of Clinical Oncology, 2010, v. 40, n. 8, p. 811, doi. 10.1093/jjco/hyq054

By:

Mukai, Hirofumi;
Takashima, Tsutomu;
Hozumi, Yasuo;
Watanabe, Takanori;
Murakami, Shigeru;
Masuda, Norikazu;
Mitsuyama, Shoshu;
Ohmura, Tousei;
Yajima, Tamiko;
Ohashi, Yasuo

Publication type:

Article

Effects of Toremifene and Tamoxifen on Lipid Profiles in Post-menopausal Patients with Early Breast Cancer: Interim Results from a Japanese Phase III Trial.

Published in:

Japanese Journal of Clinical Oncology, 2010, v. 40, n. 7, p. 627, doi. 10.1093/jjco/hyq021

By:

Tominaga, Takeshi;
Kimijima, Izo;
Kimura, Morihiko;
Takatsuka, Yuichi;
Takashima, Shigemitsu;
Nomura, Yasuo;
Kasumi, Fujio;
Yamaguchi, Akihiro;
Masuda, Norikazu;
Noguchi, Shinzaburo;
Eshima, Nobuoki

Publication type:

Article

Long-term Outcome and Pattern of Relapse after Neoadjuvant Chemotherapy in Patients with Human Epidermal Growth Factor Receptor 2-positive Primary Breast Cancer.

Published in:

Japanese Journal of Clinical Oncology, 2009, v. 39, n. 8, p. 484, doi. 10.1093/jjco/hyp052

By:

Shimizu, Chikako;
Masuda, Norikazu;
Yoshimura, Kenichi;
Tsuda, Hitoshi;
Mano, Masayuki;
Ando, Masashi;
Tamura, Kenji;
Fujiwara, Yasuhiro

Publication type:

Article

The Novel Germline Mutation of hMSH2 Gene in a Case of a Colon Cancer Patient Without Family History.

Published in:

Japanese Journal of Clinical Oncology, 2002, v. 32, n. 7, p. 266, doi. 10.1093/jjco/hyf053

By:

Ishida, Hideyuki;
Furukawa, Hiroshi;
Tatsuta, Masayuki;
Masutani, Seizo;
Imamura, Hiroshi;
Shimizu, Junzo;
Masuda, Norikazu;
Kawasaki, Takatoshi;
Satomi, Takashi;
Sugano, Kokichi;
Fukayama, Noriko;
Tomita, Naohiro

Publication type:

Article

Capecitabine in Combination with Endocrine Therapy as Maintenance Therapy after Bevacizumab Plus Paclitaxel Induction Therapy for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: KBCSG-TR1214.

Published in:

Cancers, 2021, v. 13, n. 17, p. 4399, doi. 10.3390/cancers13174399

By:

Masuda, Norikazu;
Yoshinami, Tetsuhiro;
Ikeda, Masahiko;
Mizutani, Makiko;
Yamaguchi, Miki;
Komoike, Yoshifumi;
Takashima, Tsutomu;
Yoshidome, Katsuhide;
Tsurutani, Junji;
Iwamoto, Mitsuhiko;
Fujisawa, Fumie;
Yasojima, Hiroyuki;
Yamamura, Jun;
Morishima, Hirotaka;
Aki, Fuminori;
Yamada, Tomomi;
Morita, Satoshi;
Nakayama, Takahiro

Publication type:

Article

Long-Term Outcomes of a Randomized Study of Neoadjuvant Induction Dual HER2 Blockade with Trastuzumab and Lapatinib Followed by Weekly Paclitaxel Plus Dual HER2 Blockade for HER2-Positive Primary Breast Cancer (Neo-Lath Study).

Published in:

Cancers, 2021, v. 13, n. 16, p. 4008, doi. 10.3390/cancers13164008

By:

Tokunaga, Eriko;
Masuda, Norikazu;
Yamamoto, Naohito;
Iwata, Hiroji;
Bando, Hiroko;
Aruga, Tomoyuki;
Ohtani, Shoichiro;
Fujisawa, Tomomi;
Takano, Toshimi;
Inoue, Kenichi;
Suganuma, Nobuyasu;
Takada, Masahiro;
Aogi, Kenjiro;
Sakurai, Kenichi;
Shigematsu, Hideo;
Kuroi, Katsumasa;
Haga, Hironori;
Ohno, Shinji;
Morita, Satoshi;
Toi, Masakazu

Publication type:

Article

Uncertainty of cosmetic evaluation after accelerated partial breast irradiation: interim analysis of a Japanese prospective multi-institutional feasibility study.

Published in:

2017

By:

Yoden, Eisaku;
Nose, Takayuki;
Otani, Yuki;
Asahi, Shuuji;
Tsukiyama, Iwao;
Dokiya, Takushi;
Saeki, Toshiaki;
Fukuda, Ichirou;
Sekine, Hiroshi;
Shikama, Naoto;
Kumazaki, Yu;
Takahashi, Takao;
Yoshida, Ken;
Kotsuma, Tadayuki;
Masuda, Norikazu;
Nakashima, Kazutaka;
Matsumura, Taisei;
Nakagawa, Shino;
Tachiiri, Seiji;
Moriguchi, Yoshio

Publication type:

journal article

A Japanese prospective multi-institutional feasibility study on accelerated partial breast irradiation using interstitial brachytherapy: treatment planning and quality assurance.

Published in:

Radiation Oncology, 2015, v. 10, n. 1, p. 1, doi. 10.1186/s13014-015-0430-8

By:

Yuki Otani;
Takayuki Nose;
Takushi Dokiya;
Toshiaki Saeki;
Yu Kumazaki;
Shuuji Asahi;
Iwao Tsukiyama;
Ichirou Fukuda;
Hiroshi Sekine;
Naoto Shikama;
Takao Takahashi;
Ken Yoshida;
Tadayuki Kotsuma;
Norikazu Masuda;
Eisaku Yoden;
Kazutaka Nakashima;
Taisei Matsumura;
Shino Nakagawa;
Seiji Tachiiri;
Yoshio Moriguchi

Publication type:

Article

A Japanese prospective multi-institutional feasibility study on accelerated partial breast irradiation using interstitial brachytherapy: treatment planning and quality assurance.

Published in:

Radiation Oncology, 2015, v. 10, n. 1, p. 126, doi. 10.1186/s13014-015-0430-8

By:

Yuki Otani;
Takayuki Nose;
Takushi Dokiya;
Toshiaki Saeki;
Yu Kumazaki;
Shuuji Asahi;
Iwao Tsukiyama;
Ichirou Fukuda;
Hiroshi Sekine;
Naoto Shikama;
Takao Takahashi;
Ken Yoshida;
Tadayuki Kotsuma;
Norikazu Masuda;
Eisaku Yoden;
Kazutaka Nakashima;
Taisei Matsumura;
Shino Nakagawa;
Seiji Tachiiri;
Yoshio Moriguchi

Publication type:

Article

A Japanese prospective multi-institutional feasibility study on accelerated partial breast irradiation using interstitial brachytherapy: treatment planning and quality assurance.

Published in:

2015

By:

Otani, Yuki;
Nose, Takayuki;
Dokiya, Takushi;
Saeki, Toshiaki;
Kumazaki, Yu;
Asahi, Shuuji;
Tsukiyama, Iwao;
Fukuda, Ichirou;
Sekine, Hiroshi;
Shikama, Naoto;
Takahashi, Takao;
Yoshida, Ken;
Kotsuma, Tadayuki;
Masuda, Norikazu;
Yoden, Eisaku;
Nakashima, Kazutaka;
Matsumura, Taisei;
Nakagawa, Shino;
Tachiiri, Seiji;
Moriguchi, Yoshio

Publication type:

journal article

Time-series blood cytokine profiles correlate with treatment responses in triple-negative breast cancer patients.

Published in:

British Journal of Cancer, 2024, v. 130, n. 6, p. 1023, doi. 10.1038/s41416-023-02527-0

By:

Saldajeno, Don Pietro;
Kawaoka, Shinpei;
Masuda, Norikazu;
Tanaka, Sunao;
Bando, Hiroko;
Nishimura, Tomomi;
Kadoya, Takayuki;
Yamanaka, Takashi;
Imoto, Shigeru;
Velaga, Ravindranath M.;
Tamura, Nobuko;
Aruga, Tomoyuki;
Ikeda, Kazushi;
Fukui, Yukiko;
Maeshima, Yurina;
Takada, Masahiro;
Suzuki, Eiji;
Ueno, Takayuki;
Ogawa, Seishi;
Haga, Hironori

Publication type:

Article

Phase 1 trial of entinostat as monotherapy and combined with exemestane in Japanese patients with hormone receptor-positive advanced breast cancer.

Published in:

2021

By:

Masuda, Norikazu;
Tamura, Kenji;
Yasojima, Hiroyuki;
Shimomura, Akihiko;
Sawaki, Masataka;
Lee, Min-Jung;
Yuno, Akira;
Trepel, Jane;
Kimura, Ryoko;
Nishimura, Yozo;
Saji, Shigehira;
Iwata, Hiroji

Publication type:

journal article

Real-world effectiveness of post-trastuzumab emtansine treatment in patients with HER2-positive, unresectable and/or metastatic breast cancer: a retrospective observational study (KBCSG-TR 1917).

Published in:

2021

By:

Nakayama, Takahiro;
Yoshinami, Tetsuhiro;
Yasojima, Hiroyuki;
Kittaka, Nobuyoshi;
Takahashi, Masato;
Ohtani, Shoichiro;
Kim, Seung Jin;
Kurakami, Hiroyuki;
Yamamoto, Naoko;
Yamada, Tomomi;
Takata, Takehiko;
Masuda, Norikazu

Publication type:

journal article

Dose response of pegfilgrastim in Japanese breast cancer patients receiving six cycles of docetaxel, doxorubicin, and cyclophosphamide therapy: a randomized controlled trial.

Published in:

2015

By:

Masuda, Norikazu;
Tokuda, Yutaka;
Nakamura, Seigo;
Shimazaki, Ryutaro;
Ito, Yoshinori;
Tamura, Kazuo

Publication type:

journal article

Phase III placebo-controlled, double-blind, randomized trial of pegfilgrastim to reduce the risk of febrile neutropenia in breast cancer patients receiving docetaxel/cyclophosphamide chemotherapy.

Published in:

Supportive Care in Cancer, 2015, v. 23, n. 4, p. 1137, doi. 10.1007/s00520-014-2597-1

By:

Kosaka, Yoshimasa;
Rai, Yoshiaki;
Masuda, Norikazu;
Takano, Toshimi;
Saeki, Toshiaki;
Nakamura, Seigo;
Shimazaki, Ryutaro;
Ito, Yoshinori;
Tokuda, Yutaka;
Tamura, Kazuo

Publication type:

Article

A phase III open-label study to assess safety and efficacy of palonosetron for preventing chemotherapy-induced nausea and vomiting (CINV) in repeated cycles of emetogenic chemotherapy.

Published in:

Supportive Care in Cancer, 2012, v. 20, n. 7, p. 1507, doi. 10.1007/s00520-011-1239-0

By:

Aogi, Kenjiro;
Sakai, Hiroshi;
Yoshizawa, Hirohisa;
Masuda, Norikazu;
Katakami, Nobuyuki;
Yanagita, Yasuhiro;
Inoue, Kenichi;
Kuranami, Masaru;
Mizutani, Mitsuhiro;
Masuda, Noriyuki

Publication type:

Article

Prospective assessment of chemotherapy-induced peripheral neuropathy due to weekly paclitaxel in patients with advanced or metastatic breast cancer (CSP-HOR 02 study).

Published in:

2009

By:

Kuroi, Katsumasa;
Shimozuma, Kojiro;
Ohashi, Yasuo;
Hisamatsu, Kazufumi;
Masuda, Norikazu;
Takeuchi, Ayano;
Aranishi, Toshihiko;
Morita, Satoshi;
Ohsumi, Shozo;
Hausheer, Frederick H

Publication type:

journal article

Olaparib monotherapy for Asian patients with a germline BRCA mutation and HER2-negative metastatic breast cancer: OlympiAD randomized trial subgroup analysis.

Published in:

Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-63033-4

By:

Im, Seock-Ah;
Xu, Binghe;
Li, Wei;
Robson, Mark;
Ouyang, Quchang;
Yeh, Dah-Cherng;
Iwata, Hiroji;
Park, Yeon Hee;
Sohn, Joo Hyuk;
Tseng, Ling-Ming;
Goessl, Carsten;
Wu, Wenting;
Masuda, Norikazu

Publication type:

Article

Potential value of ctDNA monitoring in metastatic HR + /HER2 − breast cancer: longitudinal ctDNA analysis in the phase Ib MONALEESASIA trial.

Published in:

BMC Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12916-023-03017-z

By:

Chiu, Joanne;
Su, Fei;
Joshi, Mukta;
Masuda, Norikazu;
Ishikawa, Takashi;
Aruga, Tomoyuki;
Zarate, Juan Pablo;
Babbar, Naveen;
Balbin, O. Alejandro;
Yap, Yoon-Sim

Publication type:

Article

Preliminary results from ASCENT-J02: a phase 1/2 study of sacituzumab govitecan in Japanese patients with advanced solid tumors.

Published in:

International Journal of Clinical Oncology, 2024, v. 29, n. 11, p. 1684, doi. 10.1007/s10147-024-02589-x

By:

Naito, Yoichi;
Nakamura, Seigo;
Kawaguchi-Sakita, Nobuko;
Ishida, Takanori;
Nakayama, Takahiro;
Yamamoto, Yutaka;
Masuda, Norikazu;
Matsumoto, Koji;
Kogawa, Takahiro;
Sudo, Kazuki;
Shimomura, Akihiko;
Lai, Catherine;
Zhang, Danjie;
Iwahori, Yuki;
Gary, Dianna;
Huynh, Danh;
Iwata, Hiroji

Publication type:

Article

Correction to: Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19).

Published in:

2022

By:

Aogi, Kenjiro;
Watanabe, Kenichi;
Kitada, Masahiro;
Sangai, Takafumi;
Ohtani, Shoichiro;
Aruga, Tomoyuki;
Kawaguchi, Hidetoshi;
Fujisawa, Tomomi;
Maeda, Shigeto;
Morimoto, Takashi;
Sato, Nobuaki;
Takao, Shintaro;
Morita, Satoshi;
Masuda, Norikazu;
Toi, Masakazu;
Ohno, Shinji

Publication type:

Correction Notice

Palbociclib as an early-line treatment for Japanese patients with hormone receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer: a review of clinical trial and real-world data.

Published in:

International Journal of Clinical Oncology, 2021, v. 26, n. 12, p. 2179, doi. 10.1007/s10147-021-02013-8

By:

Masuda, Norikazu;
Kosaka, Nobuyoshi;
Iwata, Hiroji;
Toi, Masakazu

Publication type:

Article

Correction to: Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19).

Published in:

2021

By:

Aogi, Kenjiro;
Watanabe, Kenichi;
Kitada, Masahiro;
Sangai, Takafumi;
Ohtani, Shoichiro;
Aruga, Tomoyuki;
Kawagichi, Hidetoshi;
Fujisawa, Tomomi;
Maeda, Shigeto;
Morimoto, Takashi;
Sato, Nobuaki;
Takao, Shintaro;
Morita, Satoshi;
Masuda, Norikazu;
Toi, Masakazu;
Ohno, Shinji

Publication type:

Correction Notice

Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19).

Published in:

International Journal of Clinical Oncology, 2021, v. 26, n. 7, p. 1229, doi. 10.1007/s10147-021-01920-0

By:

Aogi, Kenjiro;
Watanabe, Kenichi;
Kitada, Masahiro;
Sangai, Takashi;
Ohtani, Shoichiro;
Aruga, Tomoyuki;
Kawagichi, Hidetoshi;
Fujisawa, Tomomi;
Maeda, Shigeto;
Morimoto, Takashi;
Sato, Nobuaki;
Takao, Shintaro;
Morita, Satoshi;
Masuda, Norikazu;
Toi, Masakazu;
Ohno, Shinji

Publication type:

Article

Palbociclib in combination with fulvestrant in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-3 subgroup analysis of Japanese patients.

Published in:

International Journal of Clinical Oncology, 2019, v. 24, n. 3, p. 262, doi. 10.1007/s10147-018-1359-3

By:

Masuda, Norikazu;
Inoue, Kenichi;
Nakamura, Rikiya;
Rai, Yoshiaki;
Mukai, Hirofumi;
Ohno, Shinji;
Hara, Fumikata;
Mori, Yuko;
Hashigaki, Satoshi;
Muramatsu, Yasuaki;
Nagasawa, Takashi;
Umeyama, Yoshiko;
Huang, Xin;
Iwata, Hiroji

Publication type:

Article

Palbociclib in combination with letrozole in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-2 subgroup analysis of Japanese patients.

Published in:

International Journal of Clinical Oncology, 2019, v. 24, n. 3, p. 274, doi. 10.1007/s10147-018-1353-9

By:

Mukai, Hirofumi;
Shimizu, Chikako;
Masuda, Norikazu;
Ohtani, Shoichiro;
Ohno, Shinji;
Takahashi, Masato;
Yamamoto, Yutaka;
Nishimura, Reiki;
Sato, Nobuaki;
Ohsumi, Shozo;
Iwata, Hiroji;
Mori, Yuko;
Hashigaki, Satoshi;
Muramatsu, Yasuaki;
Nagasawa, Takashi;
Umeyama, Yoshiko;
Lu, Dongrui R.;
Toi, Masakazu

Publication type:

Article

Safety, pharmacokinetics and efficacy findings in an open-label, single-arm study of weekly paclitaxel plus lapatinib as first-line therapy for Japanese women with HER2-positive metastatic breast cancer.

Published in:

International Journal of Clinical Oncology, 2015, v. 20, n. 6, p. 1102, doi. 10.1007/s10147-015-0832-5

By:

Inoue, Kenichi;
Kuroi, Katsumasa;
Shimizu, Satoru;
Rai, Yoshiaki;
Aogi, Kenjiro;
Masuda, Norikazu;
Nakayama, Takahiro;
Iwata, Hiroji;
Nishimura, Yuichiro;
Armour, Alison;
Sasaki, Yasutsuna

Publication type:

Article

Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients.

Published in:

International Journal of Clinical Oncology, 2015, v. 20, n. 4, p. 709, doi. 10.1007/s10147-015-0785-8

By:

Yamshiro, Hiroyasu;
Iwata, Hiroji;
Masuda, Norikazu;
Yamamoto, Naohito;
Nishimura, Reiki;
Ohtani, Shoichiro;
Sato, Nobuki;
Takahashi, Masato;
Kamio, Takako;
Yamazaki, Kosuke;
Saito, Tsuyoshi;
Kato, Makoto;
Lee, Tecchuu;
Ohno, Shinji;
Kuroi, Katsumasa;
Takano, Toshimi;
Takada, Masahiro;
Yasuno, Shinji;
Morita, Satoshi;
Toi, Masakazu

Publication type:

Article

Erratum to: Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients.

Published in:

2015

By:

Yamshiro, Hiroyasu;
Iwata, Hiroji;
Masuda, Norikazu;
Yamamoto, Naohito;
Nishimura, Reiki;
Ohtani, Shoichiro;
Sato, Nobuaki;
Takahashi, Masato;
Kamio, Takako;
Yamazaki, Kosuke;
Saito, Tsuyoshi;
Kato, Makoto;
Lee, Tecchuu;
Ohno, Shinji;
Kuroi, Katsumasa;
Takano, Toshimi;
Takada, Masahiro;
Yasuno, Shinji;
Morita, Satoshi;
Toi, Masakazu

Publication type:

Erratum

The present state and perception of young women with breast cancer towards breast reconstructive surgery.

Published in:

International Journal of Clinical Oncology, 2015, v. 20, n. 2, p. 324, doi. 10.1007/s10147-014-0716-0

By:

Nozawa, Keiko;
Ichimura, Miho;
Oshima, Akira;
Tokunaga, Eriko;
Masuda, Norikazu;
Kitano, Atsuko;
Fukuuchi, Atsushi;
Shinji, Ono

Publication type:

Article